A Bioequivalence Study of an Acetylcysteine 2% Oral Solution Versus a Reference Fluimucil 2% Oral Solution
Clinical trial NCT02688361 · COMPLETED
Trial details
- NCT number
- NCT02688361
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-22
- Primary completion
- 2016-04-13
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.